169 related articles for article (PubMed ID: 7682476)
1. [Tumor markers in the diagnosis of lung cancer].
Marel M; Bíbrová L; Melínová L; Potocková L; Svandová E
Cas Lek Cesk; 1993 Feb; 132(4):108-12. PubMed ID: 7682476
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
3. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
4. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
[TBL] [Abstract][Full Text] [Related]
6. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
7. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
8. Value of tumour and inflammatory markers in lung cancer.
Oremek GM; Sauer-Eppel H; Bruzdziak TH
Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
[TBL] [Abstract][Full Text] [Related]
9. Trophoblastic markers and CEA in non-small cell lung cancer: the comparison studies of tumour cells expression and serum concentration.
Słodkowska J; Szturmowicz M; Giedronowicz D; Rudzinski P; Sakowicz A; Kupis W
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():190-8. PubMed ID: 9337537
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
[TBL] [Abstract][Full Text] [Related]
11. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Bepler G; Jaques G; Koehler A; Gropp C; Havemann K
J Cancer Res Clin Oncol; 1987; 113(3):253-9. PubMed ID: 2438285
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of combined detection of TPS, NSE and CEA in lung cancer].
Zheng H; He BF; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):165-6. PubMed ID: 12581971
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers in lung cancer].
Niho S; Shinkai T
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391
[TBL] [Abstract][Full Text] [Related]
14. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
Ebert W; Muley T; Drings P
Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
[TBL] [Abstract][Full Text] [Related]
15. [The value of serum tumor marker in the diagnosis of lung cancer].
Shi GL; Hu XL; Yue SD; Song CX
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):299-301. PubMed ID: 15996327
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
17. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
[TBL] [Abstract][Full Text] [Related]
18. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
[TBL] [Abstract][Full Text] [Related]
19. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients.
Hillas G; Moschos C; Dimakou K; Vlastos F; Avgeropoulou S; Christakopoulou I; Rasidakis A; Bakakos P
Scand J Clin Lab Invest; 2008; 68(7):542-7. PubMed ID: 19378425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
